NCT06915831View on ClinicalTrials.gov

Type 1 Diabetes and Obstructive Sleep Apnea

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2029

Study Completion Date

August 31, 2029

Conditions
Sleep Apnea, ObstructiveType 1 Diabetes (T1D)
Interventions
DEVICE

Continuous positive airway pressure (CPAP)

All-night CPAP will be applied with bedtimes 23:00h to 7:00h.

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Chicago

OTHER